… Recently, direct oral anticoagulants (… anticoagulation management in VTE. Here, we report
on recent evidence regarding the safety of DOACs compared to traditional anticoagulants in …

… Venous thromboembolism (VTE) is a common disease associated with high risk for …
Traditionally, in the initial treatment of VTE, rapid-onset parenteral anticoagulant agents are …

… The new oral anticoagulants (NOACs), which include … of the majority of patients with venous
thromboembolism (VTE). With … Traditionally, treatment occurs in 2 overlapping steps. It starts …

… anticoagulation, and traditional anticoagulants include parenteral heparins and oral vitamin
K antagonists. Recently, new oral anticoagulant … of these direct anticoagulants and the main …

… of venous thromboembolic disease for many years. Although effective if appropriately used,
traditional anticoagulants … characteristics of traditional and new anticoagulants, as well as …

… Although traditional anticoagulants were effective in the treatment of VTE, ( 8 8. Hull R,
Delmore T, Genton E, Hirsh J, Gent M, Sackett D, et al. Warfarin sodium versus low-dose heparin …

… compared to traditional anticoagulation. Rivaroxaban is currently the only oral anticoagulant
with … We call for research to address the use of these novel anticoagulation agents for the …

… is not known, although it is expected to be much higher than that of traditional anticoagulants.
… However, they are not free from limitations, making traditional anticoagulants still the …

… Venous thromboembolism recurrence was reduced in edoxaban-treated patients with PE
and elevated NT-proBNP or with right ventricular dysfunction compared with patients who …

… anticoagulants (DOACs), such as apixaban and rivaroxaban, are becoming preferred agents
in the treatment of acute venous thromboembolism (… clearance, anticoagulant medication …